China SXT Pharmaceuticals, Inc.

SXTC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001723980

SEC filings (opens in a new tab)

No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding China SXT Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of SXTC: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	6	4	−2
Shares	236.8K	146.6K	−90.3K (−38.1%)
Value	$65.5K	$32.3K	−$33.2K (−50.7%)

New holders (1)

Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to SXTC in Q2 2023
Institution	Shares	Value	% of portfolio
Cetera Advisor Networks LLC	10,415	$2.45K	0.00%

Sold out (3)

Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of SXTC in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Virtu Financial LLC	39,427	$11.0K
Citadel Advisors LLC	24,410	$7.02K
UBS Group AG	17,945	$5.10K